Improving Quality & Safety in Your Endoscopy Unit (Virtual) | February 2022-03_Duloy

03_Duloy_Advanced Endoscopy

Pdf Summary

This document provides an overview of quality indicators for advanced endoscopy and upper gastrointestinal (GI) bleeding. The aim is to ensure that all patients have access to high-quality endoscopic procedures, which include correct diagnoses, appropriate therapy, and minimized risks. Quality indicators serve as benchmarks to compare performance and identify areas for improvement. The first set of quality indicators was developed in 2006 by the ASGE/ACG Task Force on Quality in Endoscopy.<br /><br />The document includes sections on quality indicators for endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), and upper GI bleeding. For ERCP, quality indicators focus on appropriate indications, complication rates, informed consent, difficulty grades, and success rates for specific procedures. Informed consent should include discussion of potential risks and failed procedures or diagnoses. EUS quality indicators address appropriate indications, complication rates, diagnostic rates for cancer, and adverse event rates.<br /><br />The section on upper GI bleeding describes quality indicators for esophagogastroduodenoscopy (EGD) and includes factors such as the frequency of endoscopic treatment for ulcers with bleeding, documenting plans for testing H. pylori infection, giving prophylactic antibiotics to cirrhosis patients with acute upper GI bleeding, and using proton pump inhibitors for suspected peptic ulcer bleeding.<br /><br />The document emphasizes the importance of maintaining high-quality care in the medical field and suggests reading the quality documents provided. It also encourages healthcare professionals to focus on meeting targets for priority indicators and to use quality improvement initiatives to address areas of improvement.

Keywords

quality indicators

advanced endoscopy

upper gastrointestinal bleeding

high-quality endoscopic procedures

ASGE/ACG Task Force

informed consent

complication rates

diagnostic rates for cancer

prophylactic antibiotics

quality improvement initiatives